Starpharma is seeking to raise between $10 million and $15 million through a placement and share purchase plan managed by Bell Potter Securities.
The shares are being offered at 65¢ each, an 8.5 per cent discount to the last close and 8.4 per cent discount to the five-day volume weighted average price.
